JP2008531558A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008531558A5 JP2008531558A5 JP2007557015A JP2007557015A JP2008531558A5 JP 2008531558 A5 JP2008531558 A5 JP 2008531558A5 JP 2007557015 A JP2007557015 A JP 2007557015A JP 2007557015 A JP2007557015 A JP 2007557015A JP 2008531558 A5 JP2008531558 A5 JP 2008531558A5
- Authority
- JP
- Japan
- Prior art keywords
- acceptable salt
- alkyl
- compound according
- pharmaceutically acceptable
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000003839 salts Chemical class 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 13
- 125000000217 alkyl group Chemical group 0.000 claims 8
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- 239000001257 hydrogen Substances 0.000 claims 8
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 6
- 150000002431 hydrogen Chemical class 0.000 claims 5
- 230000003796 beauty Effects 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims 2
- 201000004624 Dermatitis Diseases 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- BURMWZMZKMZORB-UHFFFAOYSA-N 2,2,5,7,8-pentamethyl-3,4-dihydrochromene-4,6-diol Chemical compound O1C(C)(C)CC(O)C2=C1C(C)=C(C)C(O)=C2C BURMWZMZKMZORB-UHFFFAOYSA-N 0.000 claims 1
- FBAGFYVABDVEDJ-UHFFFAOYSA-N 2,2,5-trimethyl-7-propan-2-yl-3,4-dihydrochromene-4,6-diol Chemical compound O1C(C)(C)CC(O)C2=C1C=C(C(C)C)C(O)=C2C FBAGFYVABDVEDJ-UHFFFAOYSA-N 0.000 claims 1
- HLDMYSAKQQQYRL-UHFFFAOYSA-N 2,2,7,8-tetramethyl-3,4-dihydrochromene-4,6-diol Chemical compound O1C(C)(C)CC(O)C2=C1C(C)=C(C)C(O)=C2 HLDMYSAKQQQYRL-UHFFFAOYSA-N 0.000 claims 1
- BEDVOENHMPYJKK-UHFFFAOYSA-N 4-(methoxyamino)-2,2,5,7,8-pentamethyl-3,4-dihydrochromen-6-ol Chemical compound CC1=C(O)C(C)=C2C(NOC)CC(C)(C)OC2=C1C BEDVOENHMPYJKK-UHFFFAOYSA-N 0.000 claims 1
- PIHPKOVDGXHKER-UHFFFAOYSA-N 4-(methoxyamino)-2,2,5-trimethyl-7-propan-2-yl-3,4-dihydrochromen-6-ol Chemical compound CC(C)C1=C(O)C(C)=C2C(NOC)CC(C)(C)OC2=C1 PIHPKOVDGXHKER-UHFFFAOYSA-N 0.000 claims 1
- LRZYRBQDQRAPDQ-UHFFFAOYSA-N 4-(methoxyamino)-2,2,7,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound CC1=C(O)C=C2C(NOC)CC(C)(C)OC2=C1C LRZYRBQDQRAPDQ-UHFFFAOYSA-N 0.000 claims 1
- -1 5,7-diethyl-2,2-dimethylchroman Chemical compound 0.000 claims 1
- KNTOGLWIJDQARS-UHFFFAOYSA-N 5,7-diethyl-4-(methoxyamino)-2,2,8-trimethyl-3,4-dihydrochromen-6-ol Chemical compound O1C(C)(C)CC(NOC)C2=C1C(C)=C(CC)C(O)=C2CC KNTOGLWIJDQARS-UHFFFAOYSA-N 0.000 claims 1
- CHHUURHGIOHRJW-UHFFFAOYSA-N 5-ethyl-2,2-dimethyl-7-propan-2-yl-3,4-dihydrochromene-4,6-diol Chemical compound O1C(C)(C)CC(O)C2=C1C=C(C(C)C)C(O)=C2CC CHHUURHGIOHRJW-UHFFFAOYSA-N 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 125000005865 C2-C10alkynyl group Chemical group 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 235000014676 Phragmites communis Nutrition 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 125000004434 sulfur atom Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65664405P | 2005-02-25 | 2005-02-25 | |
| PCT/US2005/044360 WO2006093547A2 (en) | 2005-02-25 | 2005-12-09 | Novel lipoxygenase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008531558A JP2008531558A (ja) | 2008-08-14 |
| JP2008531558A5 true JP2008531558A5 (OSRAM) | 2009-01-29 |
Family
ID=36941588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007557015A Withdrawn JP2008531558A (ja) | 2005-02-25 | 2005-12-09 | 新規なリポオキシゲナーゼ阻害剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060193797A1 (OSRAM) |
| EP (1) | EP1856040A4 (OSRAM) |
| JP (1) | JP2008531558A (OSRAM) |
| CN (1) | CN101128423A (OSRAM) |
| AU (1) | AU2005328327A1 (OSRAM) |
| BR (1) | BRPI0519979A2 (OSRAM) |
| CA (1) | CA2599352A1 (OSRAM) |
| MX (1) | MX2007010327A (OSRAM) |
| WO (1) | WO2006093547A2 (OSRAM) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006065686A2 (en) * | 2004-12-13 | 2006-06-22 | Galileo Pharmaceuticals, Inc. | Spiro derivatives as lipoxygenase inhibitors |
| AU2005328328A1 (en) * | 2005-02-25 | 2006-09-08 | Galileo Pharmaceuticals, Inc. | Spiro-heterocyclic chromans, thiochromans and dihydroquinolines |
| DE102007013366A1 (de) * | 2007-03-16 | 2008-09-18 | Merck Patent Gmbh | Verwendung von Chroman-4-on-Derivaten |
| EP2042172A1 (en) * | 2007-09-26 | 2009-04-01 | Inserm | Use of tocopherol derivatives as inhibitors of the notch signalling pathway |
| HRP20140988T1 (hr) * | 2008-06-25 | 2014-12-05 | Array Biopharma, Inc. | Derivati 6-supstituirane fenoksikromankarboksilne kiseline |
| US20110136898A1 (en) * | 2008-08-05 | 2011-06-09 | University College Cork, National University Of Ireland, Cork | Treatment of retinal degeneration |
| LU91562B1 (en) * | 2009-05-04 | 2010-11-05 | Axoglia Therapeutics S A | Hydroquinone derivatives. |
| MX2013009961A (es) * | 2011-03-01 | 2013-09-26 | Npharmakon Llc | Uso de n-(4-metoxifenil)-1-fenil-1h-pirazol-3-amina y compuestos relacionados. |
| CN102775376B (zh) * | 2012-08-25 | 2014-04-09 | 云南民族大学 | 一种色烷酮类化合物及其制备方法和应用 |
| EP3036226B1 (en) | 2013-08-22 | 2020-01-08 | The General Hospital Corporation | Inhibitors of human 12/15-lipoxygenase |
| EP3054936B1 (en) | 2013-10-10 | 2023-10-18 | Eastern Virginia Medical School | 4-((2-hydroxy-3-methoxybenzyl)amino) benzenesulfonamide derivatives as 12-lipoxygenase inhibitors |
| JP2017088496A (ja) * | 2014-03-19 | 2017-05-25 | 三菱化学株式会社 | 皮膚外用剤 |
| WO2016190852A1 (en) * | 2015-05-26 | 2016-12-01 | Stealth Peptides International, Inc. | Therapeutic compositions including chromanyl compounds, variants and analogues thereof, and uses thereof |
| CN105037314B (zh) * | 2015-06-07 | 2017-10-24 | 广西师范学院 | 多肟基柚皮素衍生物及其制备方法和应用 |
| JP6853982B2 (ja) * | 2015-08-27 | 2021-04-07 | ユニバーシティ アンジェ | トコトリエノール誘導体、医薬組成物および５−リポキシゲナーゼ関連疾患における使用方法 |
| EP3818136A1 (en) | 2018-03-29 | 2021-05-12 | DSM IP Assets B.V. | Novel use of substituted 2h-chromens and their derivatives |
| WO2019185910A2 (en) | 2018-03-29 | 2019-10-03 | Dsm Ip Assets B.V. | Novel use of substituted 2h-chromens and their derivatives |
| NL2026511B1 (en) * | 2020-09-21 | 2022-05-24 | Sulfateq Bv | Compounds for treatment of heart failure |
| CN114409625B (zh) * | 2022-01-19 | 2022-08-16 | 中南民族大学 | 一种具有神经保护活性的炭角酮及其制备方法和应用 |
| CN119074731A (zh) * | 2024-09-20 | 2024-12-06 | 湖南师范大学 | 盐酸达克罗宁在预防雌性小鼠下丘脑-垂体-卵巢轴损伤中的应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3044109A1 (de) * | 1980-11-24 | 1982-06-24 | Basf Ag, 6700 Ludwigshafen | Chromanderivate sowie verfahren zu deren herstellung |
| MX13485A (es) * | 1987-10-19 | 1993-05-01 | Pfizer | Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos |
| US5021432A (en) * | 1988-04-26 | 1991-06-04 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzopyran compound and its pharmaceutical use |
| CA2124086A1 (en) * | 1991-11-22 | 1993-05-27 | Ronald H. Lane | Tocotrienols and tocotrienol-like compounds and methods for their use |
| US5414936A (en) * | 1993-09-27 | 1995-05-16 | Toxonics Manufacturing, Inc. | Adjustable archery sight |
| US6017768A (en) * | 1994-05-06 | 2000-01-25 | Pharmacopeia, Inc. | Combinatorial dihydrobenzopyran library |
| US5688997A (en) * | 1994-05-06 | 1997-11-18 | Pharmacopeia, Inc. | Process for preparing intermediates for a combinatorial dihydrobenzopyran library |
| CA2266174A1 (en) * | 1999-03-18 | 2000-09-18 | Hemosol Inc. | Hemoglobin-antioxidant conjugates |
| GR1003725B (el) * | 2000-07-12 | 2001-11-27 | Νεες ενωσεις με συνδυασμενη αντιοξειδωτικη και αντιαρρυθμικη δραση | |
| US6881396B2 (en) * | 2000-10-24 | 2005-04-19 | Diatide, Inc. | Stabilization of radiopharmaceutical compositions using hydrophilic 6-hydroxy-chromans |
| US6989138B2 (en) * | 2000-10-24 | 2006-01-24 | Diatide, Inc. | Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans |
| US20040239763A1 (en) * | 2001-06-28 | 2004-12-02 | Amir Notea | Method and apparatus for control and processing video images |
| AU2003219880A1 (en) * | 2002-02-22 | 2003-09-09 | Albany College Of Pharmacy | Methods and compounds useful in inhibiting oxidative and/or free radical damage and in the treatment and prevention of disease |
| US20060106014A1 (en) * | 2004-10-14 | 2006-05-18 | Sekhar Boddupalli | Methods for treating diabetes |
| WO2006065686A2 (en) * | 2004-12-13 | 2006-06-22 | Galileo Pharmaceuticals, Inc. | Spiro derivatives as lipoxygenase inhibitors |
-
2005
- 2005-12-09 AU AU2005328327A patent/AU2005328327A1/en not_active Abandoned
- 2005-12-09 BR BRPI0519979-4A patent/BRPI0519979A2/pt not_active IP Right Cessation
- 2005-12-09 CN CNA2005800487172A patent/CN101128423A/zh active Pending
- 2005-12-09 JP JP2007557015A patent/JP2008531558A/ja not_active Withdrawn
- 2005-12-09 CA CA002599352A patent/CA2599352A1/en not_active Abandoned
- 2005-12-09 WO PCT/US2005/044360 patent/WO2006093547A2/en not_active Ceased
- 2005-12-09 EP EP05853306A patent/EP1856040A4/en not_active Withdrawn
- 2005-12-09 MX MX2007010327A patent/MX2007010327A/es not_active Application Discontinuation
-
2006
- 2006-02-07 US US11/349,813 patent/US20060193797A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008531558A5 (OSRAM) | ||
| JP2009507909A5 (OSRAM) | ||
| JP2008539268A5 (OSRAM) | ||
| JP2014037426A5 (OSRAM) | ||
| JP2011162556A5 (OSRAM) | ||
| JP2007508360A5 (OSRAM) | ||
| JP2007508361A5 (OSRAM) | ||
| JP2006507220A5 (OSRAM) | ||
| JP2008539267A5 (OSRAM) | ||
| JP2015521167A5 (OSRAM) | ||
| CN103249697A (zh) | 适用作多巴胺能稳定剂的普利多匹定(pridopidine)氘化类似物 | |
| JP2009539828A5 (OSRAM) | ||
| JP2009535340A5 (OSRAM) | ||
| JP2012506872A5 (OSRAM) | ||
| BRPI0711370A2 (pt) | 3-(1,3-benzodioxol-5-il)-6-(4-ciclopropilpiperazin-1-il)pi ridazina e seus sais e solvatos e seu uso como antagonista receptor h3 de histamina | |
| JP2012533550A5 (OSRAM) | ||
| JP2009504748A5 (OSRAM) | ||
| JP2007522142A5 (OSRAM) | ||
| JP2009541209A5 (OSRAM) | ||
| SK141898A3 (en) | Substituted tetracyclic tetrahydrofuran derivatives | |
| JP2011500621A5 (OSRAM) | ||
| TW200304824A (en) | Nicotinamide derivatives useful as PDE4 inhibitors | |
| JP2011507879A5 (OSRAM) | ||
| JP2008512426A5 (OSRAM) | ||
| MX2010002576A (es) | Compuestos que contienen guanidina, utiles como antagonistas de los receptores muscarinicos. |